User profiles for D.-s. Kong

David Sun Kong

Director, Community Biotechnology Initiative, MIT Media Lab
Verified email at mit.edu
Cited by 963

Enabling microfluidics: from clean rooms to makerspaces

DI Walsh, DS Kong, SK Murthy, PA Carr - Trends in biotechnology, 2017 - cell.com
The traditional requirement for clean rooms and specialized skills has inhibited many biologists
from pursuing new microfluidic innovations. Makerspaces provide a growing alternative …

Microvascular decompression for treating hemifacial spasm: lessons learned from a prospective study of 1,174 operations

SJ Hyun, DS Kong, K Park - Neurosurgical review, 2010 - Springer
The authors critically analyzed a large series of patients with hemifacial spasm (HFS) and
who underwent microvascular decompression (MVD) under a prospective protocol. We …

The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment

N Chang, SH Ahn, DS Kong, HW Lee… - Molecular and cellular …, 2017 - Elsevier
Glioblastoma multiforme (GBM) is the most aggressive form of cancer that begins within the
brain; generally, the patient has a dismal prognosis and limited therapeutic options. Signal …

[HTML][HTML] Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas

KM Joo, SY Kim, X Jin, SY Song, DS Kong, JII Lee… - Laboratory …, 2008 - Elsevier
A number of recent reports have demonstrated that only CD133-positive cancer cells of
glioblastoma multiforme (GBM) have tumor-initiating potential. These findings raise an attractive …

[PDF][PDF] Spatiotemporal evolution of the primary glioblastoma genome

…, Y Kim, SH Nam, BS Kim, MD Johnson, DS Kong… - Cancer cell, 2015 - cell.com
Tumor recurrence following treatment is the major cause of mortality for glioblastoma multiforme
(GBM) patients. Thus, insights on the evolutionary process at recurrence are critical for …

Spatiotemporal genomic architecture informs precision oncology in glioblastoma

…, S Shin, YJ Seo, JM Oh, YJ Shin, CK Park, DS Kong… - Nature …, 2017 - nature.com
Precision medicine in cancer proposes that genomic characterization of tumors can inform
personalized targeted therapies 1 , 2 , 3 , 4 , 5 . However, this proposition is complicated by …

[PDF][PDF] Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ

…, J Muradov, H Yang, YL Choi, WY Park, DS Kong… - Cell reports, 2013 - cell.com
Frequent discrepancies between preclinical and clinical results of anticancer agents
demand a reliable translational platform that can precisely recapitulate the biology of human …

Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6 …

DS Kong, ST Kim, EH Kim, DH Lim… - American Journal …, 2011 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Methylation of the MGMT gene promoter is associated
with a favorable prognosis in adult patients with GBM treated with TMZ. We determined the …

Prognostic significance of c‐Met expression in glioblastomas

DS Kong, SY Song, DH Kim, KM Joo, JS Yoo, JS Koh… - Cancer, 2009 - Wiley Online Library
BACKGROUD: The authors investigated whether expression of c‐Met protein in glioblastomas
is associated with overall survival and biologic features representing tumor invasiveness …

Changes in soil and vegetation following stabilisation of dunes in the southeastern fringe of the Tengger Desert, China

XR Li, DS Kong, HJ Tan, XP Wang - Plant and Soil, 2007 - Springer
Abstract Properties of the soil and sand-binding vegetation were measured at five sites plus
a control on dunes of the Tengger Desert stabilized for periods of up to 50 years. In the …